Versor Investments’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-38,777
| Closed | -$3.08M | – | 178 |
|
|
2025
Q4 | $3.08M | Buy |
38,777
+2,082
| +6% | +$164K | 0.48% | 30 |
|
|
2025
Q3 | $2.77M | Sell |
36,695
-17,798
| -33% | -$1.22M | 0.51% | 20 |
|
|
2025
Q2 | $3.76M | Buy |
54,493
+34,193
| +168% | +$2.24M | 0.66% | 12 |
|
|
2025
Q1 | $1.38M | Buy |
20,300
+11,100
| +121% | +$664K | 0.22% | 115 |
|
|
2024
Q4 | $413K | Buy |
9,200
+3,300
| +56% | +$185K | 0.07% | 450 |
|
|
2024
Q3 | $371K | Buy |
+5,900
| New | +$344K | 0.06% | 522 |
|
|
2024
Q2 | – | Sell |
-15,706
| Closed | -$1.25M | – | 768 |
|
|
2024
Q1 | $1.25M | Sell |
15,706
-1,200
| -7% | -$91.7K | 0.25% | 89 |
|
|
2023
Q4 | $1.33M | Buy |
16,906
+8,765
| +108% | +$624K | 0.27% | 70 |
|
|
2023
Q3 | $568K | Sell |
8,141
-9,620
| -54% | -$682K | 0.12% | 254 |
|
|
2023
Q2 | $1.23M | Sell |
17,761
-7,355
| -29% | -$523K | 0.21% | 59 |
|
|
2023
Q1 | $1.87M | Sell |
25,116
-1,367
| -5% | -$115K | 0.24% | 47 |
|
|
2022
Q4 | $2.47M | Buy |
26,483
+13,916
| +111% | +$1.34M | 0.21% | 29 |
|
|
2022
Q3 | $1.2M | Sell |
12,567
-26,549
| -68% | -$2.63M | 0.07% | 176 |
|
|
2022
Q2 | $3.62M | Buy |
39,116
+12,349
| +46% | +$1.21M | 0.14% | 44 |
|
|
2022
Q1 | $2.71M | Buy |
26,767
+5,669
| +27% | +$596K | 0.1% | 42 |
|
|
2021
Q4 | $2.18M | Sell |
21,098
-252
| -1% | -$23.3K | 0.07% | 49 |
|
|
2021
Q3 | $1.81M | Buy |
21,350
+4,152
| +24% | +$348K | 0.06% | 61 |
|
|
2021
Q2 | $1.44M | Buy |
17,198
+14,300
| +493% | +$1.17M | 0.05% | 57 |
|
|
2021
Q1 | $218K | Buy |
+2,898
| New | +$211K | 0.01% | 219 |
|
|
2020
Q4 | – | Sell |
-21,722
| Closed | -$1.27M | – | 152 |
|
|
2020
Q3 | $1.27M | Buy |
21,722
+7,700
| +55% | +$479K | 0.11% | 54 |
|
|
2020
Q2 | $911K | Buy |
+14,022
| New | +$883K | 0.09% | 27 |
|
|
2020
Q1 | – | Sell |
-13,100
| Closed | -$973K | – | 267 |
|
|
2019
Q4 | $973K | Buy |
+13,100
| New | +$920K | 0.05% | 156 |
|
|
2017
Q4 | – | Sell |
-3,824
| Closed | -$311K | – | 250 |
|
|
2017
Q3 | $311K | Buy |
+3,824
| New | +$302K | 0.1% | 120 |
|
|
2017
Q2 | – | Sell |
-5,797
| Closed | -$455K | – | 192 |
|
|
2017
Q1 | $455K | Buy |
+5,797
| New | +$463K | 0.18% | 42 |
|
Other funds holding CVS
VCM
VPM
Versor Investments's CVS Position: Q1 2026 in Review
Versor Investments sold out of CVS Health (CVS) in Q1 2026, closing a stake of 38,777 shares — an estimated $3.08M sold.
Versor Investments first reported a position in CVS in Q1 2017 and held it in 24 quarters. The position peaked at $3.76M in Q2 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Versor Investments reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
- Versor Investments sold 38,777 CVS Health shares in Q1 2026, an estimated $3.08M.
- Versor Investments first reported a position in CVS Health in Q1 2017 and held it in 24 quarters.
- Versor Investments's CVS Health position peaked at $3.76M in Q2 2025.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.